Oaktree Acquisition Corp. III Life Sciences (OACC) Shares Outstanding (Weighted Average) (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $5.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (changed 0.0% YoY), and the FY2025 full-year result was $4.0 million, down 15.84% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $5.4 million, up from $4.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $19.2 million in Q2 2025, with the low at $4.0 million in Q4 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $9.6 million across 3 years, with a median of $5.4 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) decreased 15.84% — and 2026, when it changed 0.0%.
• Oaktree Acquisition Corp. III Life Sciences' Shares Outstanding (Weighted Average) stood at $4.7 million in 2024, then retreated by 15.84% to $4.0 million in 2025, then jumped by 36.07% to $5.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $5.4 million (Q1 2026), $4.0 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.